Wei‐Jia Mo
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
Papers in
-
- RNA modifications and cancer 10
- RNA Research and Splicing 5
- Bioinformatics and Genomic Networks 3
- Cancer-related gene regulation 3
-
- Cancer-related molecular mechanisms research 9
- MicroRNA in disease regulation 3
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Gang Chen (20 shared papers)Zhen‐Bo Feng (10 shared papers)Dianzhong Luo (4 shared papers)Huiping Lu (6 shared papers)Lanshan Huang (3 shared papers)Rong‐Quan He (7 shared papers)Jia Li (2 shared papers)Hong Yang (5 shared papers)
- Journals
- International Journal of Oncology (3 papers)Oncology Reports (2 papers)World Journal of Clinical Oncology (1 paper)Cancer Biotherapy and Radiopharmaceuticals (1 paper)Cancer Medicine (1 paper)
- Partner nations
- China
In The Last Decade
Wei‐Jia Mo
29 papers receiving 362 citations
Peers
Comparison fields: 5 of 56
- Cancer Research 174
- Molecular Biology 225
- Pulmonary and Respiratory Medicine 48
- Oncology 29
- Pathology and Forensic Medicine 15
Countries citing papers authored by Wei‐Jia Mo
This map shows the geographic impact of Wei‐Jia Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Jia Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Jia Mo more than expected).
Fields of papers citing papers by Wei‐Jia Mo
This network shows the impact of papers produced by Wei‐Jia Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Jia Mo. The network helps show where Wei‐Jia Mo may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei‐Jia Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 53 | |
| 2 | 2017 | 28 | |
| 3 | 2017 | 24 | |
| 4 | 2020 | 22 | |
| 5 | Identification of miR-101-3p targets and functional features based on bioinformatics, meta-analysis and experimental verification in hepatocellular carcinoma. | 2017 | 21 |
| 6 | 2018 | 21 | |
| 7 | 2018 | 18 | |
| 8 | Overexpressed BSG related to the progression of lung adenocarcinoma with high-throughput data-mining, immunohistochemistry, in vitro validation and in silico investigation. | 2019 | 16 |
| 9 | Integrated assessment of CDK1 upregulation in thyroid cancer. | 2019 | 16 |
| 10 | 2018 | 15 | |
| 11 | 2018 | 15 | |
| 12 | 2020 | 14 | |
| 13 | 2020 | 13 | |
| 14 | 2020 | 11 | |
| 15 | Up-regulation of Polo-like Kinase 1 in nasopharyngeal carcinoma tissues: a comprehensive investigation based on RNA-sequencing, gene chips, and in-house tissue arrays. | 2018 | 10 |
| 16 | 2018 | 10 | |
| 17 | 2018 | 8 | |
| 18 | 2020 | 7 | |
| 19 | 2020 | 7 | |
| 20 | Clinicopathological features and survival of gallbladder squamous cell carcinoma: analysis of 121 cases. | 2018 | 7 |
About Wei‐Jia Mo
Wei‐Jia Mo is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Surgery and Pathology and Forensic Medicine, having authored 30 papers that have together received 364 indexed citations. Recurring topics across this work include RNA modifications and cancer (10 papers), Cancer-related molecular mechanisms research (9 papers), RNA Research and Splicing (5 papers), Ferroptosis and cancer prognosis (4 papers), Bioinformatics and Genomic Networks (3 papers), MicroRNA in disease regulation (3 papers), Cancer-related gene regulation (3 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (174 citations), Molecular Biology (225 citations), Pulmonary and Respiratory Medicine (48 citations), Oncology (29 citations) and Pathology and Forensic Medicine (15 citations). Wei‐Jia Mo has collaborated with scholars based in China. Frequent co-authors include Gang Chen, Zhen‐Bo Feng, Dianzhong Luo, Huiping Lu, Lanshan Huang, Rong‐Quan He, Jia Li, Hong Yang, Yiwu Dang and Hanlin Wang. Their work appears in journals such as International Journal of Oncology, Oncology Reports, World Journal of Clinical Oncology, Cancer Biotherapy and Radiopharmaceuticals and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.